Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic Review
It is crucial that randomized controlled trials (RCTs) on the management of coronavirus disease 2019 (COVID-19) evaluate the outcomes that are critical to patients and clinicians, to facilitate relevance, interpretability, and comparability. This methodological systematic review describes the outcom...
Main Authors: | Alexander G. Mathioudakis, Markus Fally, Rola Hashad, Ahmed Kouta, Ali Sina Hadi, Sean Blandin Knight, Nawar Diar Bakerly, Dave Singh, Paula R. Williamson, Tim Felton, Jørgen Vestbo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/10/12/350 |
Similar Items
-
Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey
by: Alexander G. Mathioudakis, et al.
Published: (2021-03-01) -
When do we need clinical endpoint adjudication in clinical trials?
by: Claes Held
Published: (2019-01-01) -
Surrogate endpoints in trials: a call for better reporting
by: Oriana Ciani, et al.
Published: (2022-12-01) -
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database
by: Fang-Shu Ou, et al.
Published: (2023-08-01) -
Death without Previous Hospital Readmission in Patients with Heart Failure with Reduced Ejection Fraction—A New Endpoint from Old Clinical Trials
by: Jacek T. Niedziela, et al.
Published: (2022-09-01)